SPDR S&P Biotech ETF $XBI Stock Position Lowered by PFG Investments LLC

PFG Investments LLC decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,362 shares of the exchange traded fund’s stock after selling 1,337 shares during the quarter. PFG Investments LLC’s holdings in SPDR S&P Biotech ETF were worth $1,108,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of XBI. JPMorgan Chase & Co. lifted its holdings in SPDR S&P Biotech ETF by 625.1% in the 1st quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock valued at $840,983,000 after acquiring an additional 12,344,558 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of SPDR S&P Biotech ETF by 33.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock worth $1,096,866,000 after purchasing an additional 3,353,029 shares during the last quarter. Simplex Trading LLC raised its holdings in shares of SPDR S&P Biotech ETF by 116.1% in the 1st quarter. Simplex Trading LLC now owns 241,039 shares of the exchange traded fund’s stock worth $19,548,000 after purchasing an additional 1,741,445 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in SPDR S&P Biotech ETF during the first quarter valued at approximately $85,155,000. Finally, Harel Insurance Investments & Financial Services Ltd. acquired a new stake in SPDR S&P Biotech ETF during the first quarter valued at approximately $48,660,000.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $102.59 on Friday. The firm has a market cap of $5.59 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $105.47. The firm’s 50 day moving average price is $91.78 and its two-hundred day moving average price is $85.05.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.